Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04844749
Title Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent (VERU-111)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Veru Inc.
Indications

prostate adenocarcinoma

Therapies

Abiraterone

Enzalutamide

VERU-111

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.